29-Apr-2023 | D | The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2023 of the Financial Year 2022-23 and other matters.
| 24-May-2023 | |
20-May-2022 | D | Rossari Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 19, 2022, inter alia, have approved the following:
- Final Dividend of 25% (i.e. Re. 0.50/- per share) on Equity Shares of the Face Value of Rs. 2/- each for the Financial Year ended March 31, 2022, subject to approval of the Shareholders at the forthcoming Annual General Meeting ('AGM') of the Company.
Rossari Biotech Limited has informed the Exchange that record date for the purpose of Dividend is July 08, 2022.
(As per BSE Announcement Dated on 23/06/2022) | 07-Jul-2022 | |
14-May-2021 | D | Rossari Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2021, inter alia, has recommended a Final Dividend of 25% (i.e. Re. 0.50/- per share) on Equity Shares of the Face Value of Rs. 2/- each for the Financial Year ended March 31, 2021 subject to approval by the shareholders at the forthcoming Annual General Meeting the Company. | 08-Sep-2021 | |
07-Feb-2025 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday | 10-Feb-2025 | |
13-Jan-2025 | BC | Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone A | 21-Jan-2025 | |
06-Dec-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday | 09-Dec-2024 | |
30-Nov-2024 | BC | The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Kingdom of Saudi Arabia and other matters. | 30-Nov-2024 | |
19-Oct-2024 | BC | Re-appointment of Mr. Aseem Dhru (DIN: 01761455), as a Non-Executive Independent
Director of the Company | 12-Nov-2024 | |
Announcement Date29-Apr-2023
Ex Dividend Date24-May-2023
Dividend(%)25
Announcement Date20-May-2022
Ex Dividend Date07-Jul-2022
Dividend(%)25
Announcement Date14-May-2021
Ex Dividend Date08-Sep-2021
Dividend(%)25
No Bonus has been declared by ROSSARI
No Split has been declared by ROSSARI
RightsNo Rights has been declared by ROSSARI
Book Closure
10-Feb-2025 | - | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday |
21-Jan-2025 | - | Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone A |
09-Dec-2024 | - | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday |
30-Nov-2024 | - | The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Kingdom of Saudi Arabia and other matters. |
12-Nov-2024 | - | Re-appointment of Mr. Aseem Dhru (DIN: 01761455), as a Non-Executive Independent
Director of the Company |